(Q34221937)

31 July 2017

3 references

25 June 2019

21 November 2020

25 January 2021

Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review (English)

1 reference

31 July 2017

2 references

25 June 2019

21 November 2020

1 reference

25 June 2019

2 references

25 January 2021

2 references

21 November 2020

1 reference

1 reference

1

1 reference

31 July 2017

Karen F Vieira

2

1 reference

PubMed ID

20929532

31 July 2017

language of work or name

1 reference

7 October 2010

5 references

31 July 2017

13 March 2019

25 June 2019

21 November 2020

25 January 2021

5 references

31 July 2017

13 March 2019

25 June 2019

21 November 2020

25 January 2021

9

1 reference

31 July 2017

42

1 reference

Creative Commons Attribution 2.0 Generic

31 July 2017

4 references

13 March 2019

25 June 2019

21 November 2020

on focus list of Wikimedia project

25 January 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1475-2891-9-42

0 references

cites work

Omega-3 polyunsaturated fatty acids and anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Toxicity and genotoxicity evaluation of Passiflora alata Curtis (Passifloraceae).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

The complexity of the GABAA receptor shapes unique pharmacological profiles.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

First-line pharmacotherapy approaches for generalized anxiety disorder.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Natural remedies for anxiety disorders: potential use and clinical applications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Potential novel anxiolytic drugs.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Withdrawing Benzodiazepines in Primary Care

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Kava hepatotoxicity: a European view.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Complementary and alternative treatments for late-life depression, anxiety, and sleep disturbance: a review of randomized controlled trials.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Herbal and dietary supplements for treatment of anxiety disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Botanical and dietary supplements for mood and anxiety in menopausal women

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Prevalence and incidence studies of anxiety disorders: a systematic review of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Herbs and nutrients in the treatment of depression, anxiety, insomnia, migraine, and obesity.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Benzodiazepine use, abuse, and dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Importance of magnesium depletion with hypofunction of the biological clock in the pathophysiology of headhaches with photophobia, sudden infant death and some clinical forms of multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Mechanism of action of St John's wort in depression : what is known?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Kava-Kava administration reduces anxiety in perimenopausal women.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Therapeutic potential of kava in the treatment of anxiety disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

A placebo-controlled study of Kava kava in generalized anxiety disorder

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Interaction of various Piper methysticum cultivars with CNS receptors in vitro

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Pharmacotherapy of generalized anxiety disorder.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Dietary supplements used in the treatment of depression, anxiety, and sleep disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Nutritional factors in the etiology of the premenstrual tension syndromes.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Psychoactive substances of the South Seas: betel, kava and pituri

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Incidence and Duration of Side Effects and Those Rated as Bothersome With Selective Serotonin Reuptake Inhibitor Treatment for Depression

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Phytotherapy and psychiatry: bibliometric study of the scientific literature from the last 20 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Anti-anxiety studies on extracts of Passiflora incarnata Linneaus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Comparative anxiolytic activity profile of various preparations of Passiflora incarnata linneaus: a comment on medicinal plants' standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Discriminative-stimulus and time-course effects of kava-kava (Piper methysticum) in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Kavalactones and dihydrokavain modulate GABAergic activity in a rat gastric-brainstem preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Kava kava in the treatment of generalized anxiety disorder, simple phobia and specific social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

A Diet Fortified withl-lysine andl-arginine Reduces Plasma Cortisol and Blocks Anxiogenic Response to Transportation in Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

High trait anxiety in healthy subjects is associated with low neuroendocrine activity during psychosocial stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Antidepressant- and anxiolytic-like activity of magnesium in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: a double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Cardiovascular disease in persons with depressive and anxiety disorders.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Neurobiological aspects of social anxiety disorder

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Real-World Data on SSRI Antidepressant Side Effects.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Antiradical activities of the extract of Passiflora incarnata.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Treating depression comorbid with anxiety--results of an open, practice-oriented study with St John's wort WS 5572 and valerian extract in high doses.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

An open-label trial of St. John's Wort (Hypericum perforatum) in obsessive-compulsive disorder

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

Kava-kava extract in anxiety disorders: an outpatient observational study.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2891-9-42

Correct Identification of Passiflora incarnata Linn., a Promising Herbal Anxiolytic and Sedative

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2959081

St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial

28 October 2018

1 reference

12 December 2020

Differential Response to Placebo Among Patients With Social Phobia, Panic Disorder, and Obsessive-Compulsive Disorder

1 reference

12 December 2020

Neuroprotective gene profile in the brain of magnesium-deficient mice

1 reference

12 December 2020

Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial

1 reference

12 December 2020

Effect of kava extract on vagal cardiac control in generalized anxiety disorder: preliminary findings

1 reference

12 December 2020

A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo

1 reference

12 December 2020

Identifiers

DOI

10.1186/1475-2891-9-42

1 reference

PubMed ID

20929532

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference

PubMed ID

20929532